These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36749795)

  • 1. Screening and diagnostic testing protocols for HIV and Syphilis infections in health care setting in Qatar: Evaluation and recommendations.
    Nasrallah GK; Al-Buainain R; Younes N; Dargham SR; Al-Sadeq DW; Elhassan M; Al-Shaar I; Yassine HM; Abu-Raddad LJ; Emara MM; Ismail A
    PLoS One; 2023; 18(2):e0278079. PubMed ID: 36749795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance comparison of the 4th generation Bio-Rad Laboratories GS HIV Combo Ag/Ab EIA on the EVOLIS™ automated system versus Abbott ARCHITECT HIV Ag/Ab Combo, Ortho Anti-HIV 1+2 EIA on Vitros ECi and Siemens HIV-1/O/2 enhanced on Advia Centaur.
    Mitchell EO; Stewart G; Bajzik O; Ferret M; Bentsen C; Shriver MK
    J Clin Virol; 2013 Dec; 58 Suppl 1():e79-84. PubMed ID: 24342482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic accuracy of fourth-generation ARCHITECT HIV Ag/Ab Combo assay and utility of signal-to-cutoff ratio to predict false-positive HIV tests in pregnancy.
    Adhikari EH; Macias D; Gaffney D; White S; Rogers VL; McIntire DD; Roberts SW
    Am J Obstet Gynecol; 2018 Oct; 219(4):408.e1-408.e9. PubMed ID: 29913173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterophilic interference in specimens yielding false-reactive results on the Abbott 4th generation ARCHITECT HIV Ag/Ab Combo assay.
    Lavoie S; Caswell D; Gill MJ; Kadkhoda K; Charlton CL; Levett PN; Hatchette T; Garceau R; Maregmen J; Mazzulli T; Needle R; Kadivar K; Kim J
    J Clin Virol; 2018 Jul; 104():23-28. PubMed ID: 29704735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the performance of the Abbott ARCHITECT HIV Ag/Ab Combo Assay.
    Chavez P; Wesolowski L; Patel P; Delaney K; Owen SM
    J Clin Virol; 2011 Dec; 52 Suppl 1():S51-5. PubMed ID: 21983253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Optimal Cutoff Value to Predict HIV Infection Using the Architect HIV Ag/Ab Combo.
    Zhang X; Zhou X; He X; Liu X; Wang Z
    Clin Lab; 2022 Apr; 68(4):. PubMed ID: 35443578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The fourth generation Alere
    Livant E; Heaps A; Kelly C; Maharaj R; Samsunder N; Nhlangulela L; Karugaba P; Panchia R; Marrazzo J; Chirenje ZM; Parikh UM;
    J Clin Virol; 2017 Sep; 94():15-21. PubMed ID: 28710996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of the Alere Determine™ HIV-1/2 Ag/Ab Combo Rapid Test with specimens from HIV-1 seroconverters from the US and HIV-2 infected individuals from Ivory Coast.
    Masciotra S; Luo W; Youngpairoj AS; Kennedy MS; Wells S; Ambrose K; Sprinkle P; Owen SM
    J Clin Virol; 2013 Dec; 58 Suppl 1(Suppl 1):e54-8. PubMed ID: 23911678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of an alternative HIV diagnostic algorithm using the ARCHITECT HIV Ag/Ab Combo assay and potential utility of sample-to-cutoff ratio to discriminate primary from established infection.
    Ramos EM; Harb S; Dragavon J; Swenson P; Stekler JD; Coombs RW
    J Clin Virol; 2013 Dec; 58 Suppl 1(0 1):e38-43. PubMed ID: 24029686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the Architect HIV Ag/Ab Combo Assay in a low-prevalence setting: The role of samples with a low S/CO ratio.
    Alonso R; Pérez-García F; Gijón P; Collazos A; Bouza E
    J Clin Virol; 2018 Jun; 103():43-47. PubMed ID: 29635210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consistency Between Treponema pallidum Particle Agglutination Assay and Architect Chemiluminescent Microparticle Immunoassay and Characterization of Inconsistent Samples.
    Zhiyan L; Meiling W; Ping L; Jinhua D; Zhenlin Y; Zhenru F
    J Clin Lab Anal; 2015 Jul; 29(4):281-4. PubMed ID: 24840601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of early HIV infections using the fourth generation Abbott ARCHITECT HIV Ag/Ab Combo chemiluminescent microparticle immunoassay (CIA) in San Diego County.
    Manlutac AL; Giesick JS; McVay PA
    J Clin Virol; 2013 Dec; 58 Suppl 1():e44-7. PubMed ID: 24342477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sample-to-cutoff ratios using Architect HIV Ag/Ab Combo: The influence with the results of supplemental tests and optimal cutoff value to predict HIV infection.
    Wang L; Wang JY; Tian XD; Ruan JX; Yu Y; Yan F
    J Clin Lab Anal; 2019 Jun; 33(5):e22866. PubMed ID: 30803030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ARCHITECT® HIV Ag/Ab Combo assay: correlation of HIV-1 p24 antigen sensitivity and RNA viral load using genetically diverse virus isolates.
    Brennan CA; Yamaguchi J; Vallari A; Swanson P; Hackett JR
    J Clin Virol; 2013 Jun; 57(2):169-72. PubMed ID: 23485348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specificity of two HIV screening tests detecting simultaneously HIV-1 p24 antigen and antibodies to HIV-1 and -2.
    Blaich A; Buser A; Stöckle M; Gehringer C; Hirsch HH; Battegay M; Klimkait T; Frei R
    J Virol Methods; 2017 Nov; 249():143-146. PubMed ID: 28893550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance evaluation of the FDA-approved Determine™ HIV-1/2 Ag/Ab Combo assay using plasma and whole blood specimens.
    Masciotra S; Luo W; Westheimer E; Cohen SE; Gay CL; Hall L; Pan Y; Peters PJ; Owen SM
    J Clin Virol; 2017 Jun; 91():95-100. PubMed ID: 28372891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of different confirmatory algorithms using seven treponemal tests on Architect Syphilis TP-positive/RPR-negative sera.
    Jonckheere S; Berth M; Van Esbroeck M; Blomme S; Lagrou K; Padalko E
    Eur J Clin Microbiol Infect Dis; 2015 Oct; 34(10):2041-8. PubMed ID: 26187433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of Abbott Fourth Generation HIV Antigen and Antibody Assays.].
    Kang HJ; Yoo KH; Kim HS; Cho HC
    Korean J Lab Med; 2006 Feb; 26(1):39-44. PubMed ID: 18156698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the virtues and pitfalls in an HIV screening algorithm based on two fourth generation assays - A step towards an improved national algorithm.
    Avidor B; Chemtob D; Turner D; Zeldis I; Girshengorn S; Matus N; Achsanov S; Gielman S; Schweizer I; Baskin L; Schreiber L; Kra-Oz Z
    J Clin Virol; 2018 Sep; 106():18-22. PubMed ID: 30007138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV infection in Xi'an, China: epidemic characterization, risk factors to false positives and potential utility of the sample-to-cutoff index to identify true positives using Architect HIV Ag/Ab combo.
    Wang L; Xiao Y; Tian XD; Ruan JX; Chen W; Yu Y
    Antimicrob Resist Infect Control; 2019; 8():9. PubMed ID: 30651975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.